150 related articles for article (PubMed ID: 28436560)
21. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
[TBL] [Abstract][Full Text] [Related]
22. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.
Josephy PD; Evans DH; Parikh A; Guengerich FP
Chem Res Toxicol; 1998 Jan; 11(1):70-4. PubMed ID: 9477228
[TBL] [Abstract][Full Text] [Related]
23. Roles of human sulfotransferases in genotoxicity of carcinogens using genetically engineered umu test strains.
Oda Y; Zhang Y; Buchinger S; Reifferscheid G; Yang M
Environ Mol Mutagen; 2012 Mar; 53(2):152-64. PubMed ID: 22072630
[TBL] [Abstract][Full Text] [Related]
24. Heterologous expression of human N-acetyltransferases 1 and 2 and sulfotransferase 1A1 in Salmonella typhimurium for mutagenicity testing of heterocyclic amines.
Muckel E; Frandsen H; Glatt HR
Food Chem Toxicol; 2002 Aug; 40(8):1063-8. PubMed ID: 12067565
[TBL] [Abstract][Full Text] [Related]
25. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
Sengstag C; Eugster HP; Würgler FE
Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
[TBL] [Abstract][Full Text] [Related]
26. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
27. Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systems.
Kranendonk M; Fisher CW; Roda R; Carreira F; Theisen P; Laires A; Rueff J; Vermeulen NP; Estabrook RW
Mutat Res; 1999 Feb; 439(2):287-300. PubMed ID: 10023085
[TBL] [Abstract][Full Text] [Related]
28. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.
Parikh A; Josephy PD; Guengerich FP
Biochemistry; 1999 Apr; 38(17):5283-9. PubMed ID: 10220313
[TBL] [Abstract][Full Text] [Related]
29. Biotransformation of (+)-fenchone by Salmonella typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase.
Nakahashi H; Yagi N; Miyazawa M
J Oleo Sci; 2013; 62(5):293-6. PubMed ID: 23648403
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains.
Josephy PD; Batty SM; Boverhof DR
Environ Mol Mutagen; 2001; 38(1):12-8. PubMed ID: 11473383
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
32. Mutagenicity of cytochrome P450 2E1 substrates in the Ames test with the metabolic competent S. typhimurium strain YG7108pin3ERb5.
Emmert B; Bünger J; Keuch K; Müller M; Emmert S; Hallier E; Westphal GA
Toxicology; 2006 Nov; 228(1):66-76. PubMed ID: 16978761
[TBL] [Abstract][Full Text] [Related]
33. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Environ Mol Mutagen; 2001; 38(4):339-46. PubMed ID: 11774366
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450 expression system for high-throughput real-time detection of genotoxicity: Application to the study of human CYP1A2 variants.
Palma BB; Moutinho D; Urban P; Rueff J; Kranendonk M
Mutat Res Genet Toxicol Environ Mutagen; 2016 Aug; 806():24-33. PubMed ID: 27476332
[TBL] [Abstract][Full Text] [Related]
35. Biotransformation of (-)-camphor by Salmonella typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase.
Nakahashi H; Miyazawa M
J Oleo Sci; 2011; 60(10):545-8. PubMed ID: 21937854
[TBL] [Abstract][Full Text] [Related]
36. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
37. Use of heterologously-expressed cytochrome P450 and glutathione transferase enzymes in toxicity assays.
Guengerich FP; Wheeler JB; Chun YJ; Kim D; Shimada T; Aryal P; Oda Y; Gillam EM
Toxicology; 2002 Dec; 181-182():261-4. PubMed ID: 12505322
[TBL] [Abstract][Full Text] [Related]
38. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocylic amines.
Kamataki T; Suzuki A; Kushida H; Iwata H; Watanabe M; Nohmi T; Fujita K
Cancer Lett; 1999 Sep; 143(2):113-6. PubMed ID: 10503888
[TBL] [Abstract][Full Text] [Related]
39. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Yanagawa Y; Sawada M; Deguchi T; Gonzalez FJ; Kamataki T
Cancer Res; 1994 Jul; 54(13):3422-7. PubMed ID: 8012961
[TBL] [Abstract][Full Text] [Related]
40. Development and progress for three decades in
Oda Y
Genes Environ; 2016; 38():24. PubMed ID: 27980699
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
